Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US Payers Rate ICER Assessment Updates Using Real World Data As Potentially ‘High Impact’
Dec 01 2020
•
By
Cathy Kelly
ICER Will Pilot Use Of RWE In Drug Assessment Updates
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Real-World Evidence
More from Clinical Trials